What is the recommended dosing and management of side effects for Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lexapro (Escitalopram) Dosing and Side Effect Management

For adults with depression, Lexapro should be started at 10 mg once daily and may be increased to 20 mg after one week if needed, with most side effects being manageable through timing adjustments, dose modifications, and supportive care. 1

Recommended Dosing

Major Depressive Disorder

  • Adults:

    • Initial dose: 10 mg once daily
    • Maximum dose: 20 mg once daily
    • Dose increases should occur after minimum of one week 1
    • Note: Fixed-dose trials showed effectiveness of both 10 mg and 20 mg, but failed to demonstrate greater benefit of 20 mg over 10 mg for most patients 1
  • Adolescents (12-17 years):

    • Initial dose: 10 mg once daily
    • Maximum dose: 20 mg once daily
    • Dose increases should occur after minimum of three weeks 1

Generalized Anxiety Disorder

  • Adults:
    • Initial dose: 10 mg once daily
    • Maximum dose: 20 mg once daily
    • Dose increases should occur after minimum of one week 1

Special Populations

  • Elderly patients: 10 mg/day recommended
  • Hepatic impairment: 10 mg/day recommended
  • Renal impairment: No dosage adjustment for mild/moderate impairment; use with caution in severe impairment 1

Administration

  • Can be taken morning or evening
  • Can be taken with or without food
  • Administer once daily 1

Common Side Effects and Management

Gastrointestinal

  • Nausea (25%):

    • Take with food
    • Consider temporary dose reduction if severe
    • Usually improves within 1-2 weeks
  • Diarrhea (25%):

    • Ensure adequate hydration
    • Take with food
    • Usually self-limiting
  • Vomiting:

    • Take with food
    • Consider temporary dose reduction

Neurological/Psychiatric

  • Headache (35%):

    • Use appropriate analgesics
    • Usually diminishes with continued treatment
  • Insomnia/somnolence:

    • For insomnia: Take in morning
    • For somnolence: Take in evening
    • Avoid alcohol
  • Dizziness:

    • Rise slowly from sitting/lying positions
    • Ensure adequate hydration
  • Anxiety/agitation:

    • May occur initially and typically subsides
    • Consider temporary dose reduction if severe

Sexual Dysfunction

  • Decreased libido, delayed orgasm, erectile dysfunction:
    • Discuss openly with patient
    • Consider dose reduction if significant impact on quality of life
    • Document sexual function before starting treatment to establish baseline 1

Other

  • Weight changes:
    • Monitor weight regularly
    • Encourage healthy diet and exercise

Discontinuation Management

  • Never discontinue abruptly
  • Implement gradual dose reduction (taper) over 10-14 days to limit withdrawal symptoms 2, 1
  • If withdrawal symptoms occur (dizziness, sensory disturbances, anxiety, irritability, insomnia):
    • Resume previous dose
    • Decrease at a more gradual rate 1

Important Precautions and Monitoring

Drug Interactions

  • MAOIs: Allow 14 days between stopping MAOI and starting escitalopram (and vice versa) 1
  • Anticoagulants/NSAIDs/Aspirin: Increased risk of bleeding 1
  • Linezolid/Methylene blue: Risk of serotonin syndrome 1

Special Warnings

  • Suicidality: Monitor closely, especially in adolescents and young adults
  • Serotonin syndrome: Watch for agitation, hallucinations, rapid heart rate, fever, excessive sweating, shivering, tremor
  • Hyponatremia: Monitor elderly patients for signs (headache, difficulty concentrating, memory impairment, confusion, weakness)
  • Angle-closure glaucoma: Risk of acute attack in anatomically narrow angles 1

Duration of Treatment

  • For major depression: Continue for several months beyond acute response
  • Periodically reassess need for maintenance treatment 1
  • For generalized anxiety disorder: Efficacy beyond 8 weeks not systematically studied 1

Escitalopram's pharmacokinetic profile shows it reaches maximum plasma concentrations in 3-4 hours, with a half-life of 27-33 hours, supporting once-daily dosing. Steady-state concentrations are achieved within 7-10 days 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The clinical pharmacokinetics of escitalopram.

Clinical pharmacokinetics, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.